Four ADA-SCID patients, including one patient that already showed immune dysregulation while on PEG-ADA, developed signs of autoimmunity, such as hemolytic anemia, thrombocytopenia, autoimmune hepatitis, and autoimmune thyroiditis (Aiuti et al., 2009 and unpublished observation). The gene discussed is ADA; the disease is Autoimmunity.